Month: May 2015

  • May 5, 2015 – "Conducting a Freedom to Operate Investigation" (American Intellectual Property Law Association) – 12:30 – 2:00 pm (Eastern) May 12, 2015 – "Patent Prosecution: Leveraging Declarations to Strengthen Patents Against Post-Grant Proceedings" (Strafford) – 1:00 to 2:30 pm (EDT) May 12, 2015 – 31st Annual Joint Patent Practice Seminar (Connecticut, New Jersey,…

  • The American Intellectual Property Law Association (AIPLA) will be offering a webinar on "Conducting a Freedom to Operate Investigation" on May 5, 2015 from 12:30 – 2:00 pm (Eastern).  Les Bookoff of Bookoff McAndrews, ​Susie Jones of Jones Robb, PLLC, and Bill Shaw of Biogen Idec will explore the role of freedom to operate investigations…

  • Practising Law Institute (PLI) will be holding its Fundamentals of Patent Prosecution 2015: A Boot Camp for Claim Drafting & Amendment Writing seminar on May 12-14, 2015 in Chicago, IL, on June 15-17, 2015 in New York, NY, and on July 8-10, 2015 in San Francisco, CA.  The three-day program, which is directed to patent…

  • Strafford will be offering a webinar/teleconference entitled "Navigating Section 112(a) Enablement and Written Description — Withstanding 112(a) Rejections and Attacks on Patent Validity and Patentability" on June 4, 2015 from 1:00 to 2:30 pm (EDT).  Rekha Bansal, Sr. Director of IP, Principia Biopharma; and Thomas L. Irving, Dr. Jill K. MacAlpine, Deborah M. Herzfeld, and…

  • American Conference Institute (ACI) will be holding a conference on Biosimilars on June 1-2, 2015 in New York, NY.  ACI faculty will help attendees: • FDA's approval of Sandoz's Zarxio biosimilar: Analysis of FDA standards for labeling, biosimilarity, interchangeability, and clinical studies;• Reviewing the biosimilars litigation cases to date including Sandoz v. Amgen and Celltrion…

  • Strafford will be offering a webinar/teleconference entitled "Hedge Fund IPR Challenges to Pharma Patents: Strategies to Strengthen Patents to Withstand Attack" on May 28, 2015 from 1:00 to 2:30 pm (EDT).  Rekha Bansal, Sr. Director of IP, Principia Biopharma; and Thomas L. Irving, Dr. Amanda K. Murphy, and Dr. Barbara R. Rudolph of Finnegan Henderson…